A New Telomerase Inhibitor And Apoptosis-Inducing Agent In Leukemia: Perylene Derivative G-Quadruplex Ligand Tel03

Bin Chu,Gu Yuan,Jiang Zhou,Yuan Ou,Ping Zhu
DOI: https://doi.org/10.1002/ddr.20248
2008-01-01
Drug Development Research
Abstract:Tel03 (N,N'-Bis-(2-(dimethylamino)ethyl)-3,4,9,10-perylentetra-carboxylic acid diimide), a perylene derivative, was synthesized and its interaction with different forms of human telomeric DNA examined. The effect of Tel03 on leukemia cells in short-term Cultures was also used to explore its molecular actions. Electrospray ionization mass spectrometry (ESI-MS) analysis indicated that Tel03 specifically recognizes telomeric quadruplex, not duplex DNA. After the treatment with Tel03 (0.1-10 mu M) for 48h, telomerase activity in K562 leukemia cell extracts was inhibited in a dose-dependent manner as assessed with a telomere repeat amplification protocol (TRAP) assay. MTT assay results showed that Tel03 (0.1-10 mu M) inhibited the proliferation of K562 cells after treatment for 72 h. In addition, apoptosis was observed. Using real-time quantitative PCR and Western Not analysis, the expression of c-myc and bcl-2 was markedly down-regulated at both the mRNA and protein levels. However, no changes were observed in the expression of bax. We conclude that G-quadruplex ligand, Tel03, is a novel telomerase inhibitor and apoptosis-inducing agent in leukemia cells acting via down-regulation of bcl-2 and c-myc. Tel03 has the potential to be developed as an antileukemia drug.
What problem does this paper attempt to address?